Darolutamide Archives - Medical Conferences

Meet the Trialist: Prof. Fred Saad shares insights from the ARANOTE trial

Expert

Prof. Fred Saad, University of Montreal Hospital Center Research Center, Canada

Trial

Phase 3, ARANOTE

Conference

ESMO 2024

25 September 2024 16:42

Darolutamide performs well across subgroups in mHSPC

Presented By

Prof. Bertrand Tombal, Université Catholique de Louvain, Belgium

Trial

Phase 3, ARASENS

Conference

EAU 2022

Type

News article

22 July 2022 12:33

Darolutamide improves OS in mHSPC

Presented By

Dr Matthew Smith, Massachusetts General Hospital Cancer Center, MA, USA

Trial

Phase 3, ARASENS

Conference

ASCO GU 2022

Type

Peer-reviewed article

8 April 2022 11:24

ASCO GU 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ASCO GU 2022

14 March 2022 07:21

ARAMIS final OS and nmCRPC safety outcomes

Expert

Prof. Karim Fizazi, Institut Gustave Roussy, France

Trial

Phase 3, ARAMIS

Conference

ASCO 2020

Type

Peer-reviewed article

17 September 2020 14:11

ARAMIS subgroup analysis: darolutamide benefits across PSADT groups

Principal Investigator

Prof. Martin Bögemann, University of Münster, Germany

Trial

Phase 3, ARAMIS

Conference

EAU 2020

Type

Peer-reviewed article

21 August 2020 13:42